Latest Period
Q1 2026
Security Snapshot
CorMedix Inc. - Common stock, $0.001 par value (CRMD) Institutional Ownership
CUSIP: 21900C308
13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026
Institutions Reporting
184
Shares (Excl. Options)
40,495,625
Price
$6.79
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, $0.001 par value
- Symbol
- CRMD on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 40,495,625
- Total 13F value
- $274,948,507
- Portfolio coverage rank
- 0%
- Share change
- -1,102,747
- Value change
- -$30,129,125
- Number of holders
- 184
- Shares outstanding
- 79,018,589
- SEC-reported price per share
- $7.51
- Insider filing price
- $7.51
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CRMD - CorMedix Inc. - Common stock, $0.001 par value is tracked under CUSIP 21900C308.
- 184 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 200 to 184 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $487,974,048 to $274,948,507.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 184 institutions filings for Q1 2026.
Security key
21900C308
Latest holder period
Q1 2026
13F holders
184
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
CRMD full holder history
CorMedix Inc. SEC filings
CorMedix Inc. company facts
CorMedix Inc. insider transactions
CorMedix Inc. 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 21900C308:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
CRMD
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 7.9% | +28% | $44,985,125 | +$9,454,283 | 6,274,076 | +27% | Deep Track Capital, LP | 31 Mar 2026 |
| SHAIBATALHAMD AYMEN ABDALKADER | 5.8% | -6.7% | $44,390,000 | -$440,330 | 4,600,000 | -0.98% | SHAIBATALHAMD AYMEN ABDALKADER | 01 Jan 2026 |
| BlackRock, Inc. | 7.5% | $41,659,221 | 4,567,897 | BlackRock, Inc. | 31 Dec 2024 |
As of 31 Mar 2026, 184 institutional investors reported holding 40,495,625 shares of CorMedix Inc. - Common stock, $0.001 par value (CRMD). This represents 51% of the company’s total 79,018,589 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
42%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 7.9% | 6,274,076 | +19% | 0.88% | $42,600,976 |
| BlackRock, Inc. | 7.6% | 5,967,575 | +3.3% | 0% | $40,519,834 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 3,129,656 | 0% | 0% | $21,250,364 |
| STATE STREET CORP | 2.8% | 2,191,843 | +14% | 0% | $14,882,614 |
| ROYCE & ASSOCIATES LP | 2.4% | 1,887,532 | +680% | 0.13% | $12,816,342 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,816,907 | -5% | 0% | $12,339,852 |
| UBS Group AG | 1.9% | 1,538,245 | +142% | 0% | $10,444,683 |
| OBERWEIS ASSET MANAGEMENT INC/ | 1.5% | 1,211,115 | +50% | 0.24% | $8,223,471 |
| Alyeska Investment Group, L.P. | 1.1% | 850,000 | 0% | 0.02% | $5,771,500 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.94% | 742,571 | 0% | 0% | $5,042,057 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.85% | 673,302 | +2.3% | 0.1% | $4,571,721 |
| NORTHERN TRUST CORP | 0.81% | 637,683 | +3.8% | 0% | $4,329,868 |
| Palisades Investment Partners, LLC | 0.77% | 610,148 | +5.8% | 1.6% | $4,143,007 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.76% | 602,966 | -1.3% | 0% | $4,094,139 |
| Trexquant Investment LP | 0.71% | 560,637 | 0.03% | $3,806,725 | |
| GOLDMAN SACHS GROUP INC | 0.65% | 511,329 | -38% | 0% | $3,471,924 |
| VANGUARD FIDUCIARY TRUST CO | 0.64% | 505,679 | 0% | 0% | $3,433,560 |
| Private Advisor Group, LLC | 0.64% | 504,668 | +33% | 0.02% | $3,426,716 |
| MARSHALL WACE, LLP | 0.64% | 502,965 | -74% | 0% | $3,415,131 |
| VICTORY CAPITAL MANAGEMENT INC | 0.63% | 499,803 | +59% | 0% | $3,393,662 |
| MORGAN STANLEY | 0.55% | 435,639 | -33% | 0% | $2,957,992 |
| Bank of New York Mellon Corp | 0.46% | 366,513 | -2.8% | 0% | $2,488,626 |
| Sculptor Capital LP | 0.43% | 335,900 | 0.03% | $2,280,761 | |
| RAYMOND JAMES FINANCIAL INC | 0.42% | 328,224 | -29% | 0% | $2,228,641 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.38% | 297,463 | -7.3% | 0% | $2,019,774 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
29
Latest
Q1 2026
Rows shown
1-25 of 29
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 40,495,625 | $274,948,507 | -$30,129,125 | $6.79 | 184 |
| 2025 Q4 | 41,963,960 | $487,974,048 | -$15,316,010 | $11.63 | 200 |
| 2025 Q3 | 43,121,910 | $501,528,237 | +$101,799,375 | $11.63 | 189 |
| 2025 Q2 | 34,151,234 | $420,699,898 | +$142,837,808 | $12.32 | 169 |
| 2025 Q1 | 23,724,937 | $146,235,596 | +$397,499 | $6.16 | 135 |
| 2024 Q4 | 22,893,836 | $185,441,545 | +$29,955,443 | $8.10 | 126 |
| 2024 Q3 | 19,135,638 | $154,655,147 | +$21,831,393 | $8.08 | 100 |
| 2024 Q2 | 17,129,390 | $74,162,669 | -$748,246 | $4.33 | 97 |
| 2024 Q1 | 17,269,642 | $73,216,929 | -$5,693,027 | $4.24 | 89 |
| 2023 Q4 | 18,742,007 | $70,461,032 | +$3,045,526 | $3.76 | 101 |
| 2023 Q3 | 17,891,223 | $66,197,207 | -$5,485,628 | $3.70 | 92 |
| 2023 Q2 | 19,187,043 | $76,065,204 | +$33,053,416 | $3.96 | 86 |
| 2023 Q1 | 10,770,110 | $44,582,136 | -$1,863,278 | $4.14 | 64 |
| 2022 Q4 | 11,182,776 | $47,050,210 | +$1,816,100 | $4.22 | 62 |
| 2022 Q3 | 10,928,271 | $31,131,890 | -$4,497,215 | $2.83 | 66 |
| 2022 Q2 | 12,425,504 | $49,348,797 | -$5,601,808 | $4.02 | 69 |
| 2022 Q1 | 13,362,668 | $73,354,516 | +$1,886,576 | $5.48 | 83 |
| 2021 Q4 | 13,046,114 | $59,435,463 | +$5,549,733 | $4.55 | 78 |
| 2021 Q3 | 11,793,247 | $54,910,109 | +$1,590,384 | $4.65 | 75 |
| 2021 Q2 | 11,351,356 | $77,873,368 | +$3,221,689 | $6.86 | 77 |
| 2021 Q1 | 10,781,064 | $107,630,096 | +$16,345,897 | $9.99 | 76 |
| 2020 Q4 | 9,261,298 | $68,791,909 | +$7,239,796 | $7.43 | 74 |
| 2020 Q3 | 8,327,514 | $50,205,664 | +$9,581,252 | $6.03 | 70 |
| 2020 Q2 | 6,739,459 | $42,456,689 | +$1,328,313 | $6.30 | 67 |
| 2020 Q1 | 6,612,416 | $23,732,293 | -$6,155,816 | $3.59 | 57 |